Daniel Minahan

Daniel Minahan

Auto-generated profile, based on publicly available information

Daniel Minahan

Department of Biomedical Engineering, University of Delaware, Newark, DE, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 October 2019 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
AAAlex Abramson
Alex Abramson
Ester Caffarel-SalvadorEster Caffarel-Salvador
Ester Caffarel-Salvador
VSVance Soares
Vance Soares
DMDaniel Minahan
Daniel Minahan
RTRyan Yu Tian
Ryan Yu Tian
GTGiovanni Traverso
Giovanni Traverso

16 November 2016 in Science Translational Medicine
Verified
Journal Article
Closed access
ABAndrew M. Bellinger
Andrew M. Bellinger
MJMousa Jafari
Mousa Jafari
TGTyler M. Grant
Tyler M. Grant
SZShiyi Zhang
Shiyi Zhang
HSHannah C. Slater
Hannah C. Slater
GTGiovanni Traverso
Giovanni Traverso
A newly developed platform capable of oral, ultra–long-acting drug delivery could be applied against the malaria vector in elimination programs.

9 January 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
AKAmeya R. Kirtane
Ameya R. Kirtane
OAOmar Abouzid
Omar Abouzid
DMDaniel Minahan
Daniel Minahan
TBTaylor Bensel
Taylor Bensel
AHAlison L. Hill
Alison L. Hill
GTGiovanni Traverso
Giovanni Traverso
The efficacy of antiretroviral therapy is significantly compromised by medication non-adherence. Long-acting enteral systems that can ease the burden of daily adherence have not yet been developed. Here we describe an oral dosage form composed of distinct drug–polymer matrices which achieved week-long systemic drug levels of the antiretrovirals dolutegravir, rilpivirine and cabotegravir in a pig. Simulations of viral dynamics and patient adherence patterns indicate that such systems would significantly reduce therapeutic failures and epidemiological modelling suggests that using such an intervention prophylactically could avert hundreds of thousands of new HIV cases. In sum, weekly administration of long-acting antiretrovirals via a novel oral dosage form is a promising intervention to help control the HIV epidemic worldwide.

22 January 2021 in Science Advances
Verified
Journal Article
Open access
PDF file
Ester Caffarel-SalvadorEster Caffarel-Salvador
Ester Caffarel-Salvador
SKSoyoung Kim
Soyoung Kim
VSVance Soares
Vance Soares
RTRyan Yu Tian
Ryan Yu Tian
SSSarah R. Stern
Sarah R. Stern
GTGiovanni Traverso
Giovanni Traverso
Microneedles with high drug-loaded tips allow fast and painless delivery of biologics into the buccal mucosa.

13 December 2018 in Advanced Materials Technologies
Verified
Journal Article
Open access
PDF file
YKYong Lin Kong
Yong Lin Kong
XZXingyu Zou
Xingyu Zou
CMCaitlin A. McCandler
Caitlin A. McCandler
AKAmeya R. Kirtane
Ameya R. Kirtane
SNShen Ning
Shen Ning
GTGiovanni Traverso
Giovanni Traverso
Long‐term implantation of biomedical electronics into the human body enables advanced diagnostic and therapeutic functionalities. However, most long‐term resident electronics devices require invasive procedures for implantation as well as a specialized receiver for communication. Here, a gastric resident electronic (GRE) system that leverages the anatomical space offered by the gastric environment to enable residence of an orally delivered platform of such devices within the human body is presented. The GRE is capable of directly interfacing with portable consumer personal electronics through Bluetooth, a widely adopted wireless protocol. In contrast to the passive day‐long gastric residence achieved with prior ingestible electronics, advancement in multimaterial prototyping enables the GRE to reside in the hostile gastric environment for a maximum of 36 d and maintain ≈15 d of wireless electronics communications as evidenced by the studies in a porcine model. Indeed, the synergistic integration of reconfigurable gastric‐residence structure, drug release modules, and wireless electronics could ultimately enable the next‐generation remote diagnostic and automated therapeutic strategies.

1 April 2017 in Gastroenterology
Verified
Journal Article
Open access
PDF file
CSCarl M. Schoellhammer
Carl M. Schoellhammer
GLGregory Y. Lauwers
Gregory Y. Lauwers
JGJeremy A. Goettel
Jeremy A. Goettel
MOMatthias A. Oberli
Matthias A. Oberli
CCCody Cleveland
Cody Cleveland
GTGiovanni Traverso
Giovanni Traverso
Background & Aims It is a challenge to deliver nucleic acids to gastrointestinal (GI) tissues due to their size and need for intracellular delivery. They are also extremely susceptible to degradation by nucleases, which are ubiquitous in the GI tract. We investigated whether ultrasound, which can permeabilize tissue through a phenomenon known as transient cavitation, can be used to deliver RNA to the colonic mucosa of living mice. Methods We investigated delivery of fluorescently labeled permeants to colon tissues of Yorkshire pigs ex vivo and mice in vivo. Colon tissues were collected and fluorescence was measured by confocal microscopy. We then evaluated whether ultrasound is effective in delivering small interfering (si)RNA to C57BL/6 mice with dextran sodium sulfate−induced colitis. Some mice were given siRNA against tumor necrosis factor ( Tnf) mRNA for 6 days; colon tissues were collected and analyzed histologically and TNF protein levels measured by enzyme-linked immunosorbent assay. Feces were collected and assessed for consistency and occult bleeding. We delivered mRNA encoding firefly luciferase to colons of healthy C57BL/6 mice. Results Exposure of ex vivo pig colon tissues to 20 kHz ultrasound for 1 minute increased the level of delivery of 3 kDa dextran 7-fold compared with passive diffusion ( P = .037); 40 kHz ultrasound application for 0.5 seconds increased the delivery 3.3-fold in living mice ( P = .041). Confocal microscopy analyses of colon tissues from pigs revealed regions of punctuated fluorescent dextran signal, indicating intracellular delivery of macromolecules. In mice with colitis, ultrasound delivery of unencapsulated siRNA against Tnf mRNA reduced protein levels of TNF in colon tissues, compared with mice with colitis given siRNA against Tnf mRNA without ultrasound ( P ≤ .014), and reduced features of inflammation ( P ≤ 4.1 × 10 −5). Separately, colons of mice administered an mRNA encoding firefly luciferase with ultrasound and the D-luciferin substrate had levels of bioluminescence 11-fold greater than colons of mice given the mRNA alone ( P = .0025). Ultrasound exposures of 40 kHz ultrasound for 0.5 seconds were well tolerated, even in mice with acute colitis. Conclusions Ultrasound can be used to deliver mRNAs and siRNAs to the colonic mucosa of mice and knock down expression of target mRNAs.